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Abstract
The mouse cytomegaloviral (MCMV) protein pM27 represents an indispensable factor for viral fitness in vivo selectively,
antagonizing signal transducer and activator of transcription 2 (STAT2)-mediated interferon signal transduction. We wished
to explore by which molecular mechanism pM27 accomplishes this effect. We demonstrate that pM27 is essential and
sufficient to curtail the protein half-life of STAT2 molecules. Pharmacologic inhibition of the proteasome restored STAT2
amounts, leading to poly-ubiquitin-conjugated STAT2 forms. PM27 was found in complexes with an essential host ubiquitin
ligase complex adaptor protein, DNA-damage DNA-binding protein (DDB) 1. Truncation mutants of pM27 showed a strict
correlation between DDB1 interaction and their ability to degrade STAT2. SiRNA-mediated knock-down of DDB1 restored
STAT2 in the presence of pM27 and strongly impaired viral replication in interferon conditioned cells, thus phenocopying
the growth attenuation of M27-deficient virus. In a constructive process, pM27 recruits DDB1 to exploit ubiquitin ligase
complexes catalyzing the obstruction of the STAT2-dependent antiviral state of cells to permit viral replication.
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Introduction
Cytomegaloviruses (CMVs) constitute prototypical b-herpesvi-
ruses. 50–95% of the global adult population are infected lifelong
with human CMV (HCMV). HCMV is a leading cause of disease
burden of newborns in western countries due to transplacental
transmission of the virus from the mother to the foetus during
pregnancy [1]. HCMV infections can also cause life-threatening
symptoms in immunocompromised individuals. As a result of an
intimately shared evolutionary history with their hosts, CMVs are
highly species-specific precluding in vivo analysis of HCMV in
small animal models, hampering our understanding of HCMV
pathogenesis. Infection of mice with mouse cytomegalovirus
(MCMV) has been proven to be a suitable model to study CMV
pathogenesis [2].
A coordinated response of interferons (IFNs) together with T-
and NK-cells controls MCMV reactivation from latency in vivo [3].
Consistently, cells with deficiencies in either the IFN induction or
the IFN signalling system show increased MCMV susceptibility
[4–9] underscoring the indispensable role of both type I (IFN-a/b)
as well as type II (IFN-c) IFN for the control of CMV replication.
IFNs directly trigger immune responses by inducing antiviral
effector mechanisms and indirectly by activating adaptive immune
responses. Thereby, IFNs constitute a constant and selecting
pressure for CMV, highlighted by the multitude of viral IFN
antagonists [10]. IFNs elicit their antiviral activity by initiating
specific transcriptional programs. Upon binding of type I IFNs to
the cognate receptor, the Janus kinase (Jak)-signal transducer and
activator of transcription (STAT) signalling cascade is activated.
Jak1 and tyrosine kinase 2 initiate a phosphorylation cascade at the
IFN receptor chain 2 and 1, respectively. The Janus kinases
phosphorylate STAT1 and STAT2. Phosphorylated STATs
dimerize due to a reciprocal SH2-phospho-Tyr-interaction. The
STAT heterodimers, together with the IFN regulatory factor 9
(IRF-9), constitute the IFN stimulated gene factor 3 (ISGF3),
which translocates to the nucleus, binds to IFN stimulated
response elements (ISRE) of IFN-inducible genes (ISGs) and
recruits the transcriptional machinery to express the respective
gene.
We identified the protein pM27 as MCMV-encoded inhibitor of
the Jak-STAT signalling cascade [11]. M27 is an early-late
expressed gene essential for reducing STAT2 amounts upon
MCMV infection. DM27-MCMV replication is attenuated upon
IFN treatment in vitro, reproducing the observed attenuation in vivo
[11,12]. Interestingly, DM27-MCMV shows a remarkable growth
reduction in IFN-c-treated cells, revealing the importance of an
IFNAR1-independent IFNGR1-initiated activation of STAT2
[11]. DM27-MCMV induces increased levels of ISGs [13] but
does not induce more IFN-b mRNA [14], consistent with the
notion that MCMV antagonizes IFN-b enhanceosome assembly
M27-independently before an ISRE-dependent positive feed-back
loop can be initiated [14].
The present study aimed to delineate the molecular mechanism
and to identify host factors exploited by pM27. Here we report
that pM27 exploits DNA-damage DNA-binding protein (DDB)1-
dependent ubiquitin (Ub)-ligase complexes to catalyze ubiquitin-
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genetic deletion of M27 from the viral genome, demonstrating that
viral fitness relies on the availability of a distinct host factor,
DDB1.
Results
The pM27-dependent reduction of STAT2 occurs
post-transcriptionally
Having demonstrated that pM27 is essential and sufficient to
decrease STAT2 amounts and that both proteins co-precipitate
[11], we intended to elucidate the mechanism of pM27. MCMV
mutants expressing C-terminal HA-epitope tagged pM27 (M27-
HA-MCMV) or pM28 (M28-HA-MCMV), the gene product of
the M28 gene directly adjacent to M27 in the MCMV genome,
were proven to be able to reduce STAT2, whereas DM27-MCMV
and UV-inactivated virus did not decrease STAT2 amounts
(Figure S1), indicating suitability of above mentioned mutants for
further analysis. A quantitative experimental setup reveals a time-
dependent decline of endogenous STAT2 amounts upon infection
with wt-MCMV but not upon infection with DM27-MCMV until
24 h post infection (Figure S2). Pre-incubation with IFN-c
significantly increased levels of STAT2 but did not comprise
pM27 function (Figure S3). During the early phase (24 h post
infection) of MCMV replication pM27 seems to be the only
MCMV-encoded protein significantly reducing STAT2 amounts
(Figure S1, S2 and S5). Nevertheless, at late times of replication
($48 h post infection) some STAT2 reduction was observed in
DM27-MCMV infected cells, raising the possibility that additional
MCMV gene products might affect STAT2 (Figure S3).
pM27 operates independent of other viral proteins since pM27-
Flag expression from a recombinant vaccinia virus (VACV) vector
(M27-Flag-VACV), but not wt-VACV or a control VACV, dose-
dependently reduced the cellular STAT2 amount in mouse M2-
10B4 cells and also in human HeLa (data not shown) and human
MRC-5 cells (Figure 1A) indicating that co-factors of pM27 are
evolutionary conserved (see below).
To elucidate the molecular mechanism of pM27, we first
constructed an expression construct encompassing the coding
sequence of the STAT2 gene devoid of the complete 39-UTR
driven by the constitutive active HCMV major IE promoter. Next,
a stably transfected cell line ectopically expressing a C-terminal
HA-epitope tagged version of STAT2 complementing STAT2-
deficient mouse fibroblasts [15] was generated, designated
STAT2-HA, which was permissive for MCMV. The transfectant
produced HA-tagged STAT2 at high levels which could be
detected either by STAT2- or HA-specific antibodies and became
tyr-phosphorylated upon type I IFN treatment, followed by
translocation into the nucleus, formation of ISGF3 complexes
and induction of IRF-1 expression (Figure S4), indicating a
preserved responsiveness and signalling function of STAT2-HA.
M27-HA-MCMV, but not DM27-MCMV, reduced the amount
of STAT2 in STAT2-HA cells (Figure S5), indicating that neither
the intrinsic STAT2 promoter nor the 39-UTR are required for
the observed reduction, in accordance with a post-transcriptional
mechanism of STAT2 depletion. To confirm the reduction of
STAT2-HA, STAT2-HA cells were infected with M27-Flag-
VACV, resulting in a loss of STAT2-HA in a time- (Figure S6) and
dose-dependent manner (Figure 1B), reproducing the data
received with endogenous STAT2. Immunofluorescence staining
revealed a decrease of STAT2 amounts upon transfection of M27
expression plasmids (Figure S7), formally ruling out an intracel-
lular sequestration of STAT2 in detergent resistant compartments.
pM27 recognizes unphosphorylated and bona fide
monomeric STAT2
VACV encodes a multitude of IFN antagonists [16] but does not
reduce STAT2 amounts (Figure 1B) while interfering with STAT2
phosphorylation and activation [17]. The ability of VACV-
expressed pM27-Flag to affect STAT2 thus suggested that STAT2
is recognized by pM27 in its unphosphorylated and bona fide
monomeric state. To test this hypothesis further, STAT1-, STAT2-,
STAT3- and IFNAR1-deficient cells were infected with M27-Flag-
VACV and the relative efficiency of pM27 to reduce the amounts of
STAT2 was analyzed. M27-Flag-VACV, but not wt-VACV,
induced the reduction of STAT2 in all cells (Figure 1C), indicating
that pM27 can recognize non-phosphorylated STAT2 molecules,
independent of their incorporation into ISGF3 complexes or
previously described STAT3:STAT2 heterodimers [18].
MCMV decreases cellular STAT2 amounts by reducing its
protein half-life
To assess if pM27 affects the pre-existing STAT2 protein pool,
STAT2 amounts were compared in presence and absence of
pM27 upon administration of the protein synthesis inhibitor
cycloheximide (CHX) and the transcription inhibitor actinomycin
D (ActD). The pM27-dependent STAT2 reduction preceded the
reduction upon blockade of de novo protein biosynthesis (Figure 2A).
5 h post MCMV infection STAT2 was hardly detectable whereas
combined treatment with CHX and ActD did not significantly
affect STAT2 - a finding which is consistent with the previously
described long half-life of STAT2 [19]. Next, pulse-chase
experiments were performed to compare the STAT2-HA half-
life in mock-infected and M27-HA-MCMV-infected cells. Cells
were labelled with
35S-L-Met/L-Cys and chased for the indicated
time (Figure 2B) before the cells were lysed and STAT2-HA
protein was precipitated. Upon infection with M27-expressing
MCMV the half-life of STAT2-HA was strongly reduced when
Author Summary
Cytomegaloviruses are strictly species-specific. Mouse
cytomegalovirus (MCMV) is a prototypical b-herpesvirus,
infecting Mus musculus as natural host and is closely
related to the human pathogenic cytomegalovirus (HCMV,
HHV-5) which both establish lifelong infection. Thus,
MCMV infection constitutes an important model for HCMV
pathogenesis. Cytomegaloviral evasion from innate immu-
nity has been observed in many respects, but the
molecular mechanisms of most viral factors are still elusive.
We recently identified the MCMV-encoded protein pM27
to be required for efficient viral replication in the presence
of interferons in vitro and to be essential in vivo.W e
identified STAT2, a mediator of interferon signalling, as
target of pM27. Here we identify the cellular machinery
exploited by pM27 to reduce the STAT2 protein half-life.
PM27 was sufficient to induce poly-ubiquitination of
STAT2, tagging it for proteasomal degradation. Since
pM27 lacks domains found within ubiquitin-ligases, we
conducted a search for cellular co-factors. We found DDB1,
an essential cellular ubiquitin-ligase complex adaptor
protein, to associate with pM27. Ablation of DDB1
increased viral susceptibility towards interferon, phenoco-
pying the attenuation of DM27-MCMV. This defines DDB1
as conditional essential host factor of CMV replication. Our
findings exemplify how cytomegaloviruses exploit an
essential host protein to circumvent innate immunity.
pM27 Uses DDB1 for Proteasomal STAT2 Degradation
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infection with DM27-MCMV either (Figure 2C). pM27 protein
longevity lasted more than 9 h (Figure 2C). Altogether, the results
demonstrated that STAT2 protein stability becomes strongly
down-regulated by pM27. Interestingly, an additional long-lived
,125 kDa protein emerged which was co-precipitated with
pM27-HA irrespectively of STAT2 presence (Figure 2C).
pM27 induces STAT2 ubiquitination and degradation
along the ubiquitin proteasome pathway
To investigate whether pM27 uses the Ub proteasome pathway,
cells were treated with MG132, an inhibitor of the proteasome.
STAT2-HA levels became largely restored and high-molecular
weight forms of STAT2 accumulated in the presence of pM27
(Figure 3A). Exploiting the intrinsic host-shut-off mechanism of
Figure 1. pM27 is essential and sufficient to reduce the amount of human and mouse STAT2. (A) Human MRC-5 and mouse M2-10B4
cells were infected (0.3 or 3 PFU/cell, 16 h) with indicated VACVs, lysed and subjected to western blotting. (B) STAT2-HA expressing cells were
infected as in (B) for 24 h. Figure 1B is part of a larger experiment which is shown in Figure S6. (C) Cells of indicated genotype were infected (5 PFU/
cell, 15 h) with wt-VACV or M27-Flag-VACV, lysed and analyzed by western blotting. Please note cross reactivity of the STAT3 antibody for STAT1.
doi:10.1371/journal.ppat.1002069.g001
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STAT2-HA amounts upon infection with wt-VACV in compar-
ison to M27-Flag-VACV in presence and absence of MG132. The
STAT2-HA half-life was drastically reduced by pM27 but could
be largely restored upon administration of MG132 (Figure S8). To
confirm this phenotype for endogenous STAT2, NIH3T3 cells
were infected with M27-Flag-VACV and treated with MG132. As
shown in Figure S9, higher molecular weight forms of STAT2
could be detected by a STAT2-specific antibody. When the cells
were infected with pM27-encoding VACV only for a short period
precluding complete STAT2 degradation, a modification of
STAT2-HA was observed in the presence of pM27-Flag and
Figure 2. pM27 affects STAT2 protein levels. (A) STAT2-HA cells were infected with indicated MCMV mutants (30 PFU/cell). Cells were
incubated with or without cycloheximide (100 mg/ml) and actinomycin D (5 mg/ml). After 1, 2 or 5 h cells were analyzed by western blotting. The
inhibitors precluded expression of pp89-IE1 and pM27-HA indicating tight inhibition. (B)
35S-L-Cys/L-Met labelled STAT2-HA cells were infected
(5 PFU/cell, 20 h). Cells were metabolically labelled (30 min) and subsequently chased for the indicated time. STAT2-HA was precipitated using an
HA-specific antibody. Proteins were separated by 8% SDS-PAGE and visualized by autoradiography. (C) As in (B), but cells were infected (20 PFU/cell)
for 90 min prior to the indicated pulse-chase regime. Asterisks indicate non-specifically precipitated proteins.
doi:10.1371/journal.ppat.1002069.g002
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modification was not seen upon expression of a non-functional
truncation mutant, pM27 1–487, in untreated or in DMSO
solvent-treated cells. The identity of STAT2 was further confirmed
by comparison with STAT2
2/2 cells (Figure 3B).
It has been demonstrated that viral gene expression and genome
replication of both CMV and VACV are blocked by inhibitors of
the proteasome [20,21]. To exclude that STAT2 restoration by
proteasome inhibitors occurs indirectly due to reduced pM27-HA
expression, CHX was co-administrated with MG132 and
lactacystin to terminate protein synthesis. Under this regime
pM27 amounts remain unchanged upon proteasome inhibition.
Nevertheless, restoration and modification of STAT2 was still
evident (Figure 3C), indicating that the proteolytic activity of the
proteasome is directly required for pM27-induced STAT2
degradation.
To corroborate that the STAT2-modifying moiety is Ub,
STAT2-HA cells were infected with M27-Flag-VACV before
treatment with MG132. STAT2-HA was precipitated and
analyzed using an Ub-specific antibody. As expected, MG132
Figure 3. pM27 facilitates the proteasome to degrade STAT2. (A) STAT2-HA cells were infected with VACV (3 PFU/cell, 8 h) expressing full-
length M27-Flag or a non-functional (M27-Flag265–682) truncation mutant and treated for 4 or 6 h with 10 mM MG132 or solvent DMSO and analyzed
by western blotting. (B) STAT2-HA and STAT2
2/2 cells were infected (3 PFU/cell, 4 h) with VACV expressing pM27-Flag or a non-functional mutant
(M27-Flag1–487), treated (4 h) with 5 or 10 mM lactacystin or DMSO and analyzed by western blotting. * indicates an unspecifically detected protein
running close to pM27-Flag. (C) STAT2-HA cells were infected (20 PFU/cell, 2 h) with DM27-MCMV or M27-HA-MCMV and incubated (3 h) with CHX
(50 mg/ml) alone or a combined treatment of CHX, lactacystin (10 mM) and MG132 (20 mM). (D) STAT2-HA cells were infected (10 PFU/cell) with M27-
Flag-VACV or wt-VACV. 4 h post infection MG132 (10 mM) was added. 24 h post infection (M27-Flag-VACV) or 20 h post infection (wt-VACV) cells
were lysed and STAT2-HA was precipitated by HA-specific antibody. Precipitated proteins were separated by SDS-PAGE and blotted. The membrane
was probed with a Ub-specific and reprobed with an HA-specific antibody.
doi:10.1371/journal.ppat.1002069.g003
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presence of pM27-Flag (Figure 3D). Higher molecular weight
forms of STAT2-HA were recognized by an Ub-specific antibody
in the presence of pM27 and MG132. In conclusion, these results
indicate that pM27 induces STAT2 ubiquitination targeting the
protein for proteasomal degradation.
pM27 binds a cellular 125 kDa protein
As we did not detect sequences or motifs that are characteristical
for Ub-ligases within M27 we surmised that pM27 serves an
indirect function to shuttle STAT2 into the Ub-proteasome
pathway. To identify potential interaction partners of pM27, a co-
immunoprecipitation (IP) strategy was ensued. STAT2-HA cells
were infected with M27-HA-MCMV and metabolically labelled.
This allowed to follow up the fate of pM27-HA and STAT2-HA
simultaneously. By comparing STAT2-HA transfectants with
STAT2
2/2 cells, pM27-HA and STAT2-HA derived co-precip-
itations could be distinguished. Interestingly, antibodies recogniz-
ing pM27-HA specifically co-precipitated a ,125 kDa protein
reproducing the observation made before (compare Figure 4A
with Figure 2C). The ,125 kDa protein was visible after pM27-
HA IP but not upon precipitation of pM28-HA (Figure 4B). The
co-precipitated protein was also observed in NIH3T3 cells and
could be freed by addition of an excess of uncoupled HA-peptides
(Figure S10), confirming that it was recovered via an epitope-
specific interaction of HA antibodies. Next, split IP samples were
simultaneously analyzed by autoradiography upon metabolic
35S-
Met/Cys-labeling and by anti-HA immunoblotting. The co-
precipitated ,125 kDa protein was visible in the autoradiography
but remained undetectable in the immunoblot with HA antibodies
(Figure 4B) indicating that it is not derived from pM27-HA.
Upon up-scaling and optimization the co-precipitated protein
could be visualized by Coomassie staining of the gels (Figure 4C).
The co-precipitating ,125 kDa protein was also observed upon
expression of pM27-Flag by a VACV (Figure 4D) confirming its
interaction with pM27. Recovery of the ,125 kDa protein was
achieved in STAT2-HA and in STAT2
2/2 cells (Figure 4D),
ruling out that the protein is STAT2, a degradation product of
STAT2 or that STAT2 is required for its interaction with pM27.
In summary, these experiments identified the ,125 kDa protein
as a novel cellular co-factor of pM27. Since pM27-Flag co-
precipitated further proteins of various sizes (Figure 4D) pM27 was
assumed to associate with a cellular multi-protein complex.
The ,125 kDa interaction partner of pM27 is DDB1
The 125 kDa band was cleaved from a Coomassie-stained gel
and analyzed by mass-spectrometry. Five peptides (YLAIAPPIIK,
ALYYLQIHPQELR, VTLGTQPTVLR, IVVFQYSDGK and
SVLLLAYKPMEGNFEEIAR) were found, all belonging to
DDB1, a host 127 kDa protein, concordant with the size of the
pM27 co-precipitated material. Two further replications of DDB1-
pM27-co-precipitations and subsequent mass-spectrometry analy-
sis reached a peptide coverage rate of 24.8% and 30.2% of the
,127 kDa full length protein, respectively, unequivocally defining
DDB1 as pM27-interacting protein. DDB1 is an adapter protein
for the cellular Cul4A-RocA E3-Ub-ligase complex, previously
shown to be an interaction partner for paramyxoviral IFN
antagonists targeting STAT molecules for proteasomal degrada-
tion [22–25]. In cells, DDB1 fulfils a function as component of a
multimeric ubiquitin-ligase complex involved in nucleotide
excision repair and induces ubiquitination of the licensing factor
Cdt1 upon UV irradiation [26]. Next, the pM27-DDB1
association was confirmed by immunoblotting with a DDB1-
specific antibody upon pM27 immunoprecipitation (Figure 5A).
Moreover, STAT2 was not required for the binding of DDB1 by
pM27HA (Figure 5A). As expected, DDB1 was not retrieved upon
anti-HA IP from cells infected with wt-MCMV lacking the HA
epitope fused to the M27 sequence (Figure 5B). Conversely, DDB1
co-immunoprecipitation was seen with antibodies recognizing
pM27-Flag expressed by VACV, irrespective of the presence of
STAT2 and in the presence of MG132, confirming that the
interaction occurs independently of the epitope tag and the activity
of the proteasome (Figure 5C). The retrieval of pM27-HA-DDB1
complexes was pM27-dose-dependent (Figure S11) and resistant to
calf intestine phosphatase (CIAP), the phosphatase inhibitor NaF,
the detergent CHAPS and tolerated more than 500 mM NaCl
and up to 5 mM EDTA (data not shown), reflecting a strong
protein-protein interaction.
DDB1 is involved in UV-induced DNA damage responses, and
the UV-DDB complex consists of the two separate proteins
DDB1-p127 and DDB2-p48 [27]. Hamster cells induce signifi-
cantly less DNA-binding UV-DDB complexes due to the complete
absence of DDB2 [28]. When pM27 was expressed in Chinese
hamster ovary (CHO) cells, DDB1 was readily retrieved by co-
immunoprecipitation of pM27-HA but not pM28-HA (Figure
S12), suggesting that the interaction of the proteins can occur
independently of DDB2.
In addition to DDB1 further pM27 co-precipitated proteins
were noticed (Figure 4D). Since DDB1 acts as an adapter protein
for the Cul4A-RocA complex, we next analysed the co-
precipitation of pM27 with the scaffold protein Cul4A which
recruits the catalytic RING-finger-containing Ub-ligase RocA. A
pM27-Cul4A co-precipitation was weakly visible in mouse cells by
immunoprecipitation, presumably due to a poor reactivity of
Cul4A antibodies to mouse Cul4A. We therefore expressed pM27
in human cells resulting in a complete STAT2 down-regulation
(Figure 1A), reproducing co-precipitation of Cul4A with pM27
and DDB1 (Figure 5D). We concluded that pM27 co-precipitates
DDB1 and Cul4A irrespective of the presence of STAT2 or
DDB2.
Mutants of pM27-Flag define the minimal functional and
the DDB1 binding domain
To define the essential domain for the interaction of pM27 with
DDB1 a panel of Flag epitope tagged truncation mutants of pM27
expressing VACVs was constructed. As depicted in Figure 6A only
the truncation of the first N-terminal 68 amino acids and the last
C-terminal 30 amino acids were fully dispensable for the ability of
pM27 to induce STAT2 degradation. All functional pM27-Flag
mutants able to induce STAT2 degradation invariably co-
precipitated DDB1 (Figure 6B), revealing a correlation between
STAT2 degradation and their DDB1 binding capacity. Mutants
lacking the N- or C-terminal 195 amino acids showed a reduced
but still detectable binding to DDB1 without being able to degrade
STAT2 (Figure 6B). From the fact that neither the first 195 N-
terminal nor the last 195 amino acids were essential for DDB1
precipitation we conclude that the minimal DDB1-co-precipitating
sequence lies within aa195–487 of pM27. To corroborate this
finding, we constructed a mutant lacking the N- as well as the C-
terminus (pM27-Flag-(D5-118)-651). This mutant was still capable
to co-precipitate DDB1 upon transient transfection (data not
shown) and upon expression from a recombinant VACV
(Figure 6C).
Notably, within this minimal functional domain DxR motifs and
a conserved CxCxxC motif are present (Figure S13): Binding
partners of DDB1 have the consensus motif WDxR, or less
frequently YDxR [29,30]. PM27 contains a WD dipeptide and
four DxR sequences, one of them forming the sequence YDxR
pM27 Uses DDB1 for Proteasomal STAT2 Degradation
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on the well-described abrogation of DDB1-binding due to a single
mutation (R273H) in the DxR motif of DDB2, found in
individuals with xeroderma pigmentosum group E ([31]), we
mutated the arginine (R) to histidine (H). All four mutant proteins
were fully functional in terms of DDB1 co-precipitation (Figure 6D)
and in terms of STAT2-degradation (exemplarily shown for
R435H –Figure S14) indicating functional redundancy of these
sites or that pM27 exhibits an unusual DDB1 interaction.
SV-5 protein, a paramyxoviral DDB1-binding protein, contains
two zinc binding pockets critically required for DDB binding [32],
one of which with the sequence CxCxxC (aa206–211) [33].
Remarkably, a CxCxxC motif is also present in pM27 (aa274–279)
raising the question if pM27 is also a Zn
2+-binding protein.
Intriguingly, the CxCxxC motif is conserved throughout cytomeg-
alovirus evolution in M27 homologs with the exception of HCMV
and CCMV (Figure S13). We therefore mutated individual cysteins
to alanine.All three mutant proteins were impaired in their capacity
Figure 4. pM27 co-precipitates a ,125 kDa protein. (A) STAT2-HA (2HA) and STAT2-deficient (2
2/2) cells were infected (5 PFU/cell, 24 h) with
wt-MCMV, DM27-MCMV, M27-HA-MCMV or left uninfected. Cells were starved (1 h) and then
35S-L-Met/L-Cys labelled (150 min). Lysates were
subjected to IP using an HA-specific antibody. The asterisk indicates a non-specific protein. (B) As in (A), but cells were infected (10 PFU/cell, 48 h)
with M27-HA-MCMV, M28-HA-MCMV, wt-MCMV or left uninfected. Lysates were split and analyzed by western blotting in parallel to autoradiography.
pM28-HA forms multimers leading to the weak high-molecular weight signal in the rightmost lane. (C) As in (A), but cells were infected for 22 h. SDS-
PAGE was followed by Coomassie-staining. (D) STAT2-HA or STAT2
2/2 cells were infected (5 PFU/cell, 20 h) with M27-Flag-VACV or wt-VACV, lysed
and analyzed by HA-specific IP. Proteins were separated by SDS-PAGE and visualised by silver staining.
doi:10.1371/journal.ppat.1002069.g004
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HeLa cells and upon expression by recombinant VACVs (Figure
S14). Consistent with the hypothesis of DDB1 requirement for
pM27-mediated STAT2 degradation, the C279A mutant shows a
diminished STAT2 degradation potential (Figure S14).
pM27 but not its homolog pUL27 binds human DDB1
Like MCMV, HCMV induces a down-regulation of STAT2 in
infected cells, which is sensitive to inhibitors of the proteasome.
This effect occurs independent of pUL27, the HCMV homolog of
pM27 [34]. Consistently, pUL27 expression by VACV neither
degraded STAT2-HA nor was sufficient to co-precipitate DDB1
(Figure 6B and Figure S15). In contrast, pM27 readily co-
precipitated DDB1 in human cells (Figure 5D), consistent with the
high degree of sequence conservation of DDB1 and the functional
competence of pM27 in human cells. From this comparative
analysis between HCMV and MCMV we conclude that despite
the phenotypical match of STAT2 degradation via the ubiquitin-
proteasome pathway the genetic and molecular basis between both
viruses is remarkably different.
Knock-down of DDB1 partially restores the STAT2
amount
Recently, a floxed DDB1 allele has been cloned and recombined
into the DDB1 gene locus in mice. Global Cre-mediated DDB1
excision results in embryonic lethality [35]. Additionally, condi-
tional DDB1 gene knock-down causes a severe growth defect and
apoptosis in the chicken DT40 B cell line [36]. This approach
prompted us to carefully ablate DDB1 synthesis by siRNA to
analyze the functional relevance of DDB1 for the pM27-dependent
down-regulation of STAT2. Transfection of DDB1-specific siRNAs
induced a continuous reduction of DDB1 protein amounts (Figure
S16). To exclude that siRNA transfection influences the levels of
STAT2 due to type I IFN induction, we performed the experiment
in IFNAR1-deficient fibroblasts. As expected, infection with M27-
HA-MCMV, but not DM27-MCMV, induced STAT2 degradation
in cells treated with control siRNA. Conversely, siRNA-mediated
knock-down of pM27 restored STAT2 (Figure 7A, lanes 6 & 12).
Likewise, DDB1 ablation fully restored STAT2 amounts 4 h post
infection (lane 4) and partially after 24 h (lane 10). Consistent results
were obtained upon pM27 expression from VACV (data not
shown). These findings establish that DDB1 is a prerequisite to
execute effective STAT2 proteolysis by pM27.
siRNA-mediated knock-down of DDB1 phenocopies
M27-deficiency
M27-positive MCMVs antagonize the induction of IFN-c-
stimulated, STAT2-containing, ISRE-DNA-binding complexes
(Figure S17). Consistently,replicationof the DM27-MCMVmutant
is characterized by its enormous susceptibility towards IFN-c in vitro
Figure 5. pM27 co-precipitates with DDB1. (A) STAT2-HA and STAT2
2/2 cells were infected (5 PFU/cell, 24 h) with indicated MCMV-mutants
(wt-MCMV, M27-HA-MCMV or M28-HA-MCMV), lysed and subjected to IP using HA-specific antibody, an isotype or no antibody. Precipitated proteins
were analyzed by western blotting. (B) Infection was done as in (A). Cells were lysed and used for HA-specific IP. Precipitated proteins were analyzed
by western blotting and by silver staining. (C) STAT2-HA and STAT2
2/2 cells were infected (5 PFU/cell, 18 h) with M27-Flag-VACV, incubated with
MG132 (10 mM, for the last 4 h), lysed and subjected to IP using a Flag-specific antibody or an isotype antibody. Precipitated proteins were detected
by western blotting. (D) MRC-5 cells were infected (5 PFU/cell, 18 h) with M27-Flag-VACV, lysed and analyzed by IP with Flag-specific antibodies. The
immune complexes were separated by SDS-PAGE and analyzed by western blotting.
doi:10.1371/journal.ppat.1002069.g005
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transfected MEF with DDB1-specific- (or control-) siRNAs 48 h
prior to infection before the cells were incubated with IFN-c24 h
prior to infection. The MCMV infection was performed with a
luciferase expressing mutant, Dm157-MCMV:luciferase in which the
coding sequence of m157 has been replaced by the luciferase gene,
and cells were harvested 1, 2 and 3 days post infection. Luciferase
activity paralleled the kinetics of MCMV replication. Accordingly,
luciferase activity was inhibited upon IFN-c pretreatment of MEF
(Figure 7B, left panel). While DDB1 knock-down precluded viral
luciferase expression by the M27-positive Dm157-MCMV:luciferase
mutant in IFN-c preincubated cells, luciferase production was
unaffected in cells which were not IFN-treated (Figure 7B). The
DDB1 knock-down and reduced viral gene expression was
confirmed by western blot analysis of cell lysates using DDB1-
and pp89-IE1-specific antibodies (data not shown). The experiment
was repeated with wt-MCMV and the progeny virus yield was
quantified by standard plaque titration. IFN-c pre-treatment of
cells, which had been treated with DDB1-specific siRNA, strongly
impaired MCMV growth (Figure 7C). In clear contrast, the
replication of DM27-MCMV was highly susceptible to IFN-c and
wasnotfurtherimpairedbyablationofDDB1bysiRNA(Figure7C,
lower panel). Altogether, these data indicate that DDB1 by itself is
not required for MCMV replication. However, the virus requires
DDB1 to overcome the STAT2-dependent antiviral capacity of
IFN-cvia pM27. The phenocopy of host DDB1 depletion and viral
M27-deletion provides complementary evidence for a model in
which DDB1 is indispensable for pM27 subversion of the antiviral
IFN-c response.
Discussion
In this study we have elucidated the mechanism of the
cytomegaloviral IFN antagonist pM27. This viral protein is
Figure 6. Truncation analysis of pM27-Flag indicates correlation between DDB1 binding and STAT2 degradation. (A) The schema
depicts the generated M27 truncation mutants, all constructs are Flag-epitope tagged and expressed by recombinant VACVs. ‘27HR’ indicates a
conserved domain shared between homologous proteins of related cytomegaloviruses. (B) STAT2-HA cells were infected with the indicated pM27-
expressing VACV (16 h; 5 PFU/cell). Proteins from cell lysates were immunoprecipitated using a Flag-specific antibody (upper panel). The precipitated
proteins were detected by western blotting. A part of the lysate was acetone precipitated and used to analyse the overall protein amounts (lower
panel). (C) Cells were infected with wt-VACV or a VACV expressing a pM27-Flag protein, lacking aa 5–118 at the N-terminus and 652–682 at the C-
terminus. After precipitation with a-Flag antibody, proteins were analyzed by western blotting. (D) pIRES-EGFP plasmids expressing the indicated
pM27-Flag mutants were transiently transfected into human HeLa cells and subjected to a-Flag immunoprecipitation and subsequent western
blotting using DDB1-specific and Flag-specific antibodies.
doi:10.1371/journal.ppat.1002069.g006
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IFN signalling cascade by binding and degrading STAT2, a
transcription factor which becomes activated in the type I and type
II IFN receptor signal transduction. Replication of DM27-MCMV
is highly attenuated in IFN-treated cells and in infected mice
[11,12] indicating that STAT2 initiates an efficient antiviral
effector program unless its degradation is accomplished. pM27 is
demonstrated to degrade STAT2 via the ubiquitin proteasome
pathway by binding to DDB1 (Figure 8: Model of pM27 function).
This host factor is per se not required for MCMV replication, but
becomes conditional essential in the presence of IFN-c. From these
findings we infer a crucial role of DDB1 for MCMV replication in
vivo.
Implications of DDB1 as a cofactor for viral replication
Recently, genome-wide siRNA-based large-scale screening
approaches have been conducted to uncover host factors required
for replication of certain viruses including HIV and influenza [37–
39], representing new potential targets for antiviral therapy.
Despite the fact that relevant factors were successfully identified,
these attempts suffer from two common shortcomings. First, the
implicit counter-selection against siRNAs which are detrimental
for cell survival, i.e. a screening bias against ‘essential’ host
proteins. It is tempting to speculate that those ‘essential’ proteins
are exactly the host factors many viruses favour as interaction
partners due to their evolutionary conservation and the inability of
the host to mutate or delete the responsible genes. We feel that our
results exemplify the fundamental need to pursue ‘top-down’
approaches to refine biological observation (e.g. the growth
attenuation of DM27-MCMV upon conditioning with IFN-c)
allowing the characterization of underlying molecular mechanisms
and finally the identification of (conditional) essential host factors.
We were surprised to see that viral infection (presumably due to
control over cell cycle progression and apoptosis), increased the
ability of cells to resist knock-down of DDB1, raising the apparent
question whether it might be reasonable to conduct above
mentioned siRNA screens without any previous negative pre-
selection. Second, our study documents that distinct host factors
are not constitutively essential but become essential under certain
conditions defined by the host cell environment, e.g. the IFN-
Figure 7. siRNA mediated knock-down of DDB1 restores STAT2 amount and phenocopies M27-deficiency. (A) Primary IFNAR1-deficient
MEF cells (passage 3) were transfected with 200 nM DDB1-siRNA, M27-siRNA and an irrelevant siRNA, respectively. 24 h later cells were infected for 4
or 24 h with 10 PFU/cell M27-HA-MCMV or DM27-MCMV. Cells were lysed and subjected to western blotting. (B) Primary MEFs were transfected as in
(B), infected (0.1 PFU/cell, 48 h) with Dm157-MCMV:luc and luciferase activity was measured. (C) As in (C) but cells were infected with wt-MCMV or
DM27-MCMV and infectious virus progeny was determined by plaque titration.
doi:10.1371/journal.ppat.1002069.g007
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conditions which are closer to infected and inflamed organs leads
to additional induced essential host factors important for viral
replication because they escaped the screening performed under
standard cell culture conditions.
pM27 interaction with STAT2
pM27 has adopted a remarkable substrate specificity to capture
its cellular target, monomeric STAT2 [11]. Several findings are
fully in accord with the notion that the down-regulation of STAT2
is achieved via the ubiquitin-proteasome pathway: i) pM27
affected the half-life of STAT2, ii) STAT2 reduction was sensitive
to proteasome inhibitors, iii) in the presence of proteasome
inhibitors pM27 generated higher molecular weight forms of
STAT2, and iv) the modification of STAT2 was shown to be
conjugated Ub. Given the long protein half-life of STAT2
catalyzing its proteolytic destruction represents a direct and
immediate mechanism to shut off its antiviral function. The
recognition and binding of STAT2 requires a large and central
domain of the pM27 protein as revealed by probing of a set of
truncation mutants.
pM27 interaction with DDB1
Co-IP studies revealed the prominent binding quality of pM27
to a second host protein which was identified to be DDB1.
Forming an adaptor protein of the Cul4A-RocA Ub-ligase
complex, the linkage of pM27 with DDB1 generated the
hypothesis that pM27 delivers STAT2 to proteasomal destruction
via this factor. Two findings support the notion that DDB1 is
indeed required for the loss of STAT2 in MCMV-infected cells: i)
truncation mutants of pM27 induced the break-down of STAT2
only when their binding to DDB1 was fully intact; ii) siRNA-
mediated knock-down of DDB-1 protected STAT2 from degra-
dation.
Binding partners of DDB1 have the consensus motifs WDxR, or
less frequently YDxR [29,30]. pM27 contains a WD dipeptide and
four DxR sequences, one of them forming the sequence YDxR
(aa544–aa547). Nevertheless, single R.H mutations of the DxR
motifs did not impair DDB1 co-precipitation. This might either
indicate functional redundancy or that pM27 exhibits an
unconventional DDB1-binding mode.
Based on experimental data obtained in the fission yeast
(Schizosaccharomyces pombe), a so called DDB1-box has been defined
to be present in DDB1 binding partners like WDR21 and
comprising a RQLG-like motif surrounded by hydrophobic amino
acids in positions 27t o23 and +7o r+9 [40]. PM27 bears two
non-identical motifs, which resemble this DDB-box within aa232–
256 and aa358–377, overlapping with the domain that is required for
degradation of STAT2. Future analysis will define further essential
amino acids which are critical for DDB1-pM27-complex forma-
tion and might delineate the molecular requirements for
recruitment and exploitation of DDB1-Cul4A-RocA complexes.
The finding that the CxCxxC motif is important for DDB1 co-
precipitation suggests that pM27 harbours a coordinative Zn
2+
Figure 8. Current model of pM27 function. pM27 bridges STAT2 to DDB1-containing ubiquitin-ligase complexes thereby inducing poly-
ubiquitination and subsequent proteasomal degradation of STAT2 to antagonize induction of interferon stimulated genes.
doi:10.1371/journal.ppat.1002069.g008
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cytomegaloviruses (Figure S13), raising the apparent question
whether the basic function of the pM27 homologs, proteasomal
degradation, might also be conserved.
pM27 – not just a paramyxoviral analogue device
At the first glimpse pM27 seems to imitate paramyxoviral SV-5
V-proteins which recruit DDB1 and induce proteasomal degra-
dation of STAT proteins. Neither pM27 nor SV-5 V-protein
contain a fully conserved WDxR motif. Besides the CxCxxC
motif, pM27 and the SV-5 V-protein are considerably different
with regard to structure, function and substrate recognition and
they do not share homologous amino acid stretches. V-proteins
discriminate between human and mouse STATs and require the
presence of both STAT1 and STAT2 to induce the degradation of
the other [41,42], whereas pM27 induces the selective degradation
of human and mouse STAT2 as a monomer. Several biological
observations further imply differences in their molecular functions.
pM27 does not affect the induction of type I IFN [14] contrasting
with V-proteins [43,44]. Stable expression of pM27 was not
possible (M. Trilling, unpublished observation) but was readily
achieved for SV-5 V-protein [45], suggesting a different mode of
interaction with DDB1 which is essential for cell survival [36].
MCMV can arrest the cell cycle of infected fibroblasts both in G1
and in G2 [46]. Since DDB1 is required especially for proliferating
cells [35], an attractive hypothesis would be that MCMV can
afford a blockade of DDB1 functions due to its ability to arrest the
cell cycle prior to the DDB1-sensitive checkpoint. In line with this
hypothesis, DDB1 knock-down did not abrogate MCMV
replication in MEF by itself, but became strongly antiviral if cells
were pretreated with IFN-c. Given that DDB1 is expressed
ubiquitously in all mouse tissues [35] the conditional exploitation
of DDB1 by a proviral protein like pM27 appears to be a perfect
strategy which combines the need for a broad cell tropism to
establish ‘replication factories’ in a large variety of tissues with the
defence against the permanent encounter of omnipresent IFN-c
which is produced in response to the herpesviral life style bringing
sustained immune exposure.
Material and Methods
Cells and cytokines
MRC-5 (ATCC CCL-171), M2-10B4 (ATCC CRL-1972),
immortal STAT2
2/2- [15] and STAT1
2/2 mouse fibroblasts
[47], crisis immortalized IFNAR1-deficient (generated from
primary IFNAR1-deficient MEF [11]) and primary MEF
(prepared as described [48]) were grown in Dulbecco’s modified
eagle medium (D-MEM) with 10% foetal bovine serum,
streptomycin, penicillin and 2 mM glutamine. NIH3T3 cells were
grown in 10% newborn calf serum. STAT2-HA cells were
generated from STAT2
2/2 cells [15]. STAT2-HA [11] was
subcloned into a pcDNA3.1 (Invitrogen)-derived pcDNA3.1-
zeocin expression vector. Cell lines were selected under 200 mg/
ml zeocin (Invitrogen). IFN-c (#12500-1) was purchased from
PBL Biomedical Laboratories, New Jersey, USA. Inhibitors of the
proteasome (MG132 and lactacystin) were purchased from Boston
Biochemicals, USA.
Viruses and plasmids
swt-like MCMV MW97.01, DM27-MCMV, M27-HA-MCMV,
M27-Flag-VACV and STAT2-HA-VACV have been described
[11]. M28-HA-MCMV was generated by amplifying a frt-site
flanked kana
r-cassette using primers containing M28-homologous
sequences prolonged by an HA-epitope encoding sequence
(underlined): AZ-M28-HA1: TGCGGGCTCCGTCCGGGATA-
GCCGAGACCTGCGTGCCCACGCTCGGGTACCCATAC-
GATGTTCCAGATTACGCGTGACCAGTGAATTCGAGC-
TCGGTAC and AZ-M28-2: AGGCGAGGCGAAACTGGC-
GGGATAACTGCAAGAGAGGGGAAAAGCGGTCGATCC-
CAGCCGGACCATGATTACGCCAAGCTCC using pFRT1
as template. The PCR fragment was introduced into the MCMV-
BAC by homologous recombination in E.coli.T h ekana
r-cassette was
excised from the BAC by FLP-mediated recombination. m157 was
deleted accordingly by zeocin selection after replacement of the m157
coding sequence against a zeo
r-cassette by homologous recombination
between the MCMV-BAC and a PCR amplificate generated with the
primers: AZ-m157-1-CAGGAGAATCTGAACCCCGATATTTG-
AGAAAGTGTACCCC GATATTCAGTACCTCTTGAC CC-
AGTGAATTCGAGCTCGGTAC and AZ-m157-2-AGATCGT-
GACCATTATCACCAAGATAGTTCCCACCATAATTCC-
CATCGTCACTAGAGTCGGACCATGATTACGCCAAG-
CTCC and pFRT-Zeo as template. Afterwards zeo
r was replaced by
the luciferase gene (derived from pTA-luc [Clontech]) by homologous
recombination between the Dm157-MCMV:zeo
r BAC and a vector,
harbouring a luciferase gene flanked by 800 nts of the MCMV genome,
surrounding the m157 coding sequence. BAC-derived MCMV
mutants were reconstituted in primary MEFs und correct mutagenesis
was confirmed by restriction fragment pattern analysis and PCR (data
not shown).
Truncation mutagenesis of pM27-Flag-VACV was performed
based on the described VACV expression plasmid p7.5k131-M27-
Flag. The C-terminal sequence of the M27 ORF was amplified with
the Az-M27-m1_forw: 59-CAGAAGATCGGCACGAAGTACC-
39 primer with either the MF-M27-m2_rev: 59-CGCGCGAC-
TAGTCTCGTTGTCGTCGTCCTCGTAG-39 or - MF-M27-
m4_rev: 59-CGCGCGACTAGTGGAGCCCGACGAATCCTT-
GTC-39. Amplificates were cleaved by BamHI and SpeI (underlined,
primer intrinsic site) and cloned into p7.5k-M27Fl/SphI vector
between an N-terminal fragment of M27 and an in-frame C-
terminal Flag-epitope.
For N-terminal truncations, M27-intrinsic restriction sites (ApaI,
SacII, PvuI, NcoI, BamHI and MscI) were used together with a
vector intrinsic BglII site. After re-ligation the next ATG in frame
served as start codon. The pM27-Flag-(D5-118)-651 mutant was
constructed by replacing the C-terminal part of the D5-118 ‘SacII’
mutant with the truncated C-terminal sequence using an internal
BamHI site. VACV mutants were selected with BrdU in tk
2143
cells.
Site-directed mutagenesis of pM27-Flag was performed using
the Quick Change kit (Stratagene) according to the instructions of
the manufacturer using the following primers and its respective
reverse complementary primers: KL-C274A: 59-catctacgat-
caactcGCGtactgtcgcgagtgtc-39, KL-C276A: 59-cgatcaactctgttac-
GCGcgcgagtgtcggatgc-39, KL-C279A: 59-gttactgtcgcgagGCGcg-
gatgcgccgggg-39, KL-R435H: 59-gcgacgtcgacgccCACatccgcgcgg-
gagc-39, KL-R451H: 59-gtcgcctccgaccccCACcaggacggcatctcg-39,
KL-R477H: 59-caccttctcggacgagCACcccgacggctacgagg-39 and
KL-R547H: 59-gaggatgtacgacgagCACccgctggccggcttc-39. Muta-
tions were confirmed by sequencing.
UV inactivation of viruses (MCMV and VACV) was done by
exposing viruses for 25 min to UV light (254 nm) from a light
source 10 cm afar.
Western blotting
Cells were lysed in RIPA
+-buffer (50 mM Tris-HCl, 150 mM
NaCl, 1% [vol/vol] IGEPAL, 1% Na-Deoxycholate [vol/vol],
0.1% [weight/vol] SDS, 1 mM DTT, 0.2 mM phenylmethylsul-
fonyl fluoride (PMSF), 1 mg/ml leupeptin, 1 mg/ml pepstatin,
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inhibitors (Roche) pH 7.5). Samples were normalized according
to Bradford protein staining and equal amounts were subjected to
denaturing SDS-PAGE. Gels were blotted on nitrocellulose
membranes (Schleicher and Schuell) and probed with indicated
antibodies. The same membrane was used and consecutively
stripped with reblot solution (Calbiochem). The following
commercially available antibodies were used: a-b-actin,a-Flag
M-2 and a-HA from Sigma-Aldrich; a-IRF-9, a-STAT1, a-
mSTAT2, a-STAT3 from Santa Cruz; a-Cul4A (Acris), a-DDB1
(Bethyl), a-pp89-IE1 (Croma101, kindly provided by Stipan Jonjic ´,
Rijeka, Croatia), a-hSTAT2 (Upstate) and a-Ub (Dako).
Immunoprecipitation
Immunopreciptation was done as described. Briefly, cells were
lysed (lysisbuffer: 0.1 mM EDTA; 200 mM NaCl; 10 mM KCl;
10 mM MgCl2; 10% [vol/vol] glycerol; 20 mM HEPES [pH 7,4];
0.5% [vol/vol] IGEPAL; 0.1 mM PMSF; 1 mM DTT; 0.4 mM
pepstatin A; 0.1 mM Na-vanadate; Complete protease inhibitor
(Roche)). Lysates were spun (30 min at 4uC and 16000 g) and IP
antibody was added to the supernatant. Immune complexes were
precipitated with Protein-G-Sepharose (Amersham). The pellet
was washed by 6–10 consecutive rounds with lysis buffer.
For metabolic labelling and pulse-chase experiments cells were
starved (30 min) in L-Met-/L-Cys-free media and subsequently
pulsed (90 min) with ,10 MBq/,10
6 cells EasyTag Express
35S
protein labelling mix (PerkinElmer). After the pulse cells were
washed 3 times with chase media (10%-FBS D-MEM supple-
mented with 1.5 mg/ml L-Met/L-Cys) and chased as indicated.
Immune complexes were separated by SDS-PAGE. Gels were
either stained by silver- or Coomassie-staining or fixed, dried and
visualized by autoradiography.
siRNA Transfection
2.5–7.5 * 10
4 primary MEF cells were transfected with siRNA
using RNAiMax transfection reagent (Invitrogen) following
manufacturers instructions. The siRNAs were purchased from
IBA. The following siRNAs were used for the knockdown: DDB1
(59-[PO4] r(AACCUGUUGAUUGCCAAAAACTT)-39), luc-
siRNA (59-[PO4] r(CUUACGCUGAGUACUUCGATT)-39)
and M27 (59-[PO4] r(CAAUAAGCCCUUUAAUCAC)dTdT-39).
Supporting Information
Figure S1 M27-HA-MCMV and M28-HA-MCMV, but not
DM27-MCMV, reduces STAT2 amounts. NIH3T3 cells were
infected with wt-MCMV, UV-irradiated MCMV, indicated
MCMV mutants (5 PFU/cell, 48 h) or left uninfected. Cell lysates
were adjusted and subsequently analyzed by western blotting with
specific antibodies as indicated. All proteins were detected on one
membrane in iterated rounds of detection.
(TIF)
Figure S2 Quantification of STAT2 amounts in MCMV-
infected cells. NIH3T3 cells were infected (10 PFU/cell) with
DM27-MCMV, wt-MCMV or left uninfected. 4, 8 and 24 h post
infection cells were lysed and the endogenous STAT2 amounts
were determined by western blotting. Three western blots have
been densitometrically quantified. The arithmetic mean 6 SD of
the relative STAT2 amount compared to mock-infected cells at
the same timepoint is shown in a log10 scale.
(TIF)
Figure S3 M27 reduces STAT2 even upon induction by IFN-c
(A) Schematic overview of the experimental setup. (B) Cells were
incubated for 48 h with 500 U/ml IFN-c prior to infection with
wt-MCMV or DM27-MCMV (10 PFU/cell) for additional 48 h.
Subsequently, cells were incubated for 1 h with 250 U/ml IFN-a
or IFN-c before lysis. Lysates were normalized and analyzed by
SDS-PAGE and western blotting with the indicated antibodies.
(TIF)
Figure S4 STAT2-HA transfectant express a functional STAT2.
(A) STAT2-HA becomes tyrosine phosphorylated upon IFN
stimulation. BALB/c MEF, STAT2
2/2 cells and STAT2-HA
transfectants thereof were incubated with 50 or 500 U/ml IFN-a
for 25 min. Cells were lysed and subjected to western blotting. (B)
STAT2-HA forms ISGF3 complexes. Cells were stimulated with
25 U/ml IFN-b and native lysates were prepared and analyzed by
electromobility shift analysis (EMSA) with a
32P-labelled ISRE
probe as described before [11]. ISGF3 complexes were super-
shifted upon addition of an HA-specific antibody. (C) STAT2-HA
translocates in the nucleus upon IFN stimulation. STAT2-HA cells
were incubated for 1 h with 500 U/ml IFN-a and IFN-c.
Additionally, leptomycin B (LMB) was administered as indicated
to block the CRM-dependent protein export. Cells were fixed in
3% (v/v) PFA, permeabilized with 0.2% (v/v) Triton-X-100.
STAT2-HA was detected with an HA-specific rabbit antibody and
visualized with a Cy3-coupled secondary anti-rabbit antibody. (D)
IRF-1 can be induced in STAT2-HA cells by IFN-a. STAT2-HA
cells were incubated with grading concentrations of IFN-a and
induced amounts of IRF-1 were detected by western blotting.
(TIF)
Figure S5 M27-HA-MCMV reduces STAT2-HA amounts
whereas DM27-MCMV does not. STAT2-HA cells or the
corresponding STAT2-deficient parental cells were infected
(14 h; 5 PFU/cell) before CHX was added. Cells were directly
lysed (Pulse) or at 3, 6 and 12 h post CHX addition and the lysates
were analyzed by western blotting using the indicated antibodies.
(TIF)
Figure S6 Loss of STAT2-HA upon infection with M27-Flag-
VACV is time- and dose-dependent. A section of this experiment
is shown in Figure 1B. STAT2-HA cells or the corresponding
STAT2-deficient parental cells were infected with the indicated
VACVs. Cells were lysed at indicated timepoints and subjected to
western blotting.
(TIF)
Figure S7 Transfection of M27-expression plasmids reduces
STAT2 amounts on the level of an individual cell. STAT2-HA
cells were transfected with a pM27-Flag expression plasmid
(pIRESEGFP) using Superfect (Qiagen) transfection reagent, 24 h
later fixed (3% [v/v] PFA), permabilized (0.2% [v/v] Triton-X-
100) and stained with a-HA (rabbit), a-Flag (mouse) and secondary
anti-rabbit (Cy3-coupled) or anti-mouse (Cy5-coupled) antibodies.
IFM was done as previously described [14]. M27-transfected cells
are indicated by white arrowheads.
(TIF)
Figure S8 pM27-dependent reduction of the STAT2-HA half-
life is MG132 sensitive. STAT2-HA cells were infected with wt-
VACV, M27-Flag-VACV or left uninfected. 3 h post infection
MG132 (20 mM) was added and cells were lysed at indicated time
points. Three experiments were performed and densitometrically
quantified. Shown is the arithmetic mean 6 SD of the relative
STAT2-HA amount compared to untreated wt-VACV infected
cells. In the lower panel one representative western blot is shown.
High molecular weight forms of STAT2 become apparent in the
long exposure.
(TIF)
pM27 Uses DDB1 for Proteasomal STAT2 Degradation
PLoS Pathogens | www.plospathogens.org 13 June 2011 | Volume 7 | Issue 6 | e1002069Figure S9 pM27 induces higher molecular weight forms of
endogenous STAT2 upon incubation with MG132. NIH3T3 cells
were infected with M27-Flag-VACV or left uninfected. Cells were
incubated with 5 or 10 mg/ml MG132. Cells were lysed and
lysates were subjected to western blotting with a STAT2-specific
antibody.
(TIF)
Figure S10 pM27-HA-DDB1 co-precipitation by HA-specific
antibodies occurs epitope specific. NIH3T3 cells were infected
with indicated mutants (24 h, 5 PFU/cell) or left uninfected. Cells
were lysed and lysates were subjected to an immunoprecipitation
with HA-specific antibody. Pellets of sepharose with retrieved
immune complexes were incubated with an excess of HA-peptide
(200 mg/ml in 10 mM Tris-HCl pH 8.0 for 25 min at 37uC).
Supernatants were subjected to 8% SDS-PAGE and silver staining
(right panel). Pellets were boiled in sample loading puffer and also
analyzed by silver staining (left panel). LC, light chain, HC heavy
chain of antibodies.
(TIF)
Figure S11 pM27-DDB1 co-precipitation and STAT2-degra-
dation occur dose-dependently. STAT2-HA cells were infected
with grading titers of M27-HA-MCMV. To ensure identical
infection dose, DM27-MCMV was added to end up with a
constant infectious dose of 10 PFU/cell. Cells were lysed and
subjected to an anti-HA immunoprecipitation and subsequent
western blotting with the indicated antibodies.
(TIF)
Figure S12 pM27 co-precipitates DDB1 in hamster CHO cells
lacking DDB2. CHO cells were infected (24 h, 10 PFU/cell) with
M27-HA-MCMV or M28-HA-MCMV or left uninfected. Cells
were lysed and analyzed by immunoprecipitation with an HA-
specific antibody. Immune complexes were analyzed by SDS-
PAGE and western blotting with either an HA-specific or a
DDB1-specific antibody.
(TIF)
Figure S13 Alignment of CxCxxC motif in cytomegaloviruses.
Sequences of indicated cytomegaloviral ‘27’ proteins were
inspected for presence of CxCxxC motifs. Shown is an alignment
of the 5 known MCMV pM27 sequences (WP15A, C4A, G4A,
K181 and Smith) in comparison to the sequences derived from rat
CMV (Maastricht), aotine CMV, tupaia CMV (pT27), guinea pig
CMV (GpCMV), squirrel CMV, rhesus CMV (rhCMV), chim-
panzee CMV (CCMV), human CMV (HCMV pUL27) and the
SV-5 V-protein. The alignment was performed using Seaview
software.
(TIF)
Figure S14 Requirement of the CxCxxC motif, but not the
DxR motifs, for DDB1 association and efficient STAT2
degradation by pM27. (A) Cells were infected with VACVs
expressing indicated Flag-epitope tagged mutant proteins of
pM27. Cells were lysed and subjected to anti-Flag immunopre-
cipitation. Precipitates were separated by SDS-PAGE and probed
with Flag- and DDB1-specific antibodies. (B) NIH3T3 cells were
infected with grading concentrations of VACVs (0.3, 3 and
9 PFU/cell). Cells were lysed and analyzed by western blotting
using STAT2- and Flag-specific antibodies. An irrelevant
background band served as intrinsic loading control. All panels
are derived from the same blot and the same exposure.
(TIF)
Figure S15 pM27, but not HCMV pUL27, precipitates human
DDB1. Human MRC-5 cells were infected (3 PFU/cell) with wt-
VACV, M27-Flag-VACV or UL27-Flag-VACV. Cells were lysed
and subjected to immunoprecipitation with anti-Flag antibody, an
anti-V5 or an irrelevant control antibody. Precipitated proteins
were separated by SDS-PAGE and analyzed by western blotting
with the indicated antibodies.
(TIF)
Figure S16 siRNA-mediated ablation of DDB1. Primary MEF
cells (passage 3) were transfected with 100 nM DDB1-specific
siRNA (a luciferase-specific siRNA served as negative control),
lysed 16, 24, 48 or 72 h post transfection and DDB1 amounts were
determined by western blotting. b-actin served as protein loading
control.
(TIF)
Figure S17 IFN-c induces STAT2-containing, ISRE-DNA-
element-binding, pM27-sensitive protein complexes. NIH3T3
cells were stimulated for 24 or 48 h with IFN-c and infected
(10 PFU/cell) with wt-MCMV, DM27-MCMV or left uninfected.
Native protein lysates were prepared and an electromobility shift
assay (EMSA) was performed using an ISRE probe as described
previously [11]. STAT2-containing complexes were identified by a
super-shift, using a STAT2-specific antibody (compare to mock
lanes+IFN-c). Comparable infection can be deduced from similar
amounts of ‘CIF’ – a previously identified CMV-induced ISRE-
binding complex [49].
(TIF)
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